Biotricity issues preliminary Q1 FY2022 revenue guidance: up >45% QoQ

BIOTRICITY INC.

Revenue for Q1 ended June 30, 2021 expected to increase >45% sequentially and >280% YoY.
This would be the 9th consecutive quarter of revenue growth.
Customer base expanded to 23 states from 17 states nine months ago.
CEO cites accelerating sequential growth, high correlation between devices and TaaS revenue.
Expects consistent triple-digit revenue growth for remainder of fiscal 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.